Icagen Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Icagen Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3393
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Icagen Inc (Icagen) (formerly known as XRpro Sciences, Inc.) is a biopharmaceutical company which develops drug candidates to unmet medical needs. The company discovers drug for clinical stage across multiple therapeutics and ion class channel classes. The company provides technologies including manual and automated electrophysiology, high throughput fluorescence and radiotracer flux assays. It offers screening services to pharmaceutical sector, including the use of proprietary x-ray fluorescence technology which is marketed as XRpro. It also delivers contract research services such as ion channel and transporter screening, assay development, cell line generation and custom assay services. The company has collaborations with Pfizer, Inc. Icagen is headquartered at Durham in North Carolina, the US.

Icagen Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Icagen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Icagen Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Icagen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Icagen Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Icagen Inc, Medical Devices Deals, 2012 to YTD 2018 9
Icagen Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Icagen Inc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Icagen Acquires Arizona Research Facility from Sanofi 11
Venture Financing 12
Icagen Raises USD2 million in Venture Funding 12
Icagen Raises USD1.5 Million in Venture Financing 13
Icagen Raises USD1.2 Million in Venture Financing 14
Partnerships 15
Icagen and Omdana Therapeutics Enter into Agreement 15
Icagen Enters into Distribution Agreement with On Target 16
Icagen Partners with Aptuit 17
Albany Molecular Research Enters into Agreement with Icagen 18
Icagen Inc – Key Competitors 19
Icagen Inc – Key Employees 20
Icagen Inc – Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Government and Public Interest 22
May 01, 2018: Icagen Receives Award from the Cystic Fibrosis Foundation to Discover Transformative Therapies to Treat Cystic Fibrosis 22
Other Significant Developments 23
Jan 30, 2017: Icagen announces distribution agreement with On Target for advancing early drug discovery in Japanese market 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Icagen Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Icagen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Icagen Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Icagen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Icagen Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Icagen Inc, Medical Devices Deals, 2012 to YTD 2018 9
Icagen Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Icagen Acquires Arizona Research Facility from Sanofi 11
Icagen Raises USD2 million in Venture Funding 12
Icagen Raises USD1.5 Million in Venture Financing 13
Icagen Raises USD1.2 Million in Venture Financing 14
Icagen and Omdana Therapeutics Enter into Agreement 15
Icagen Enters into Distribution Agreement with On Target 16
Icagen Partners with Aptuit 17
Albany Molecular Research Enters into Agreement with Icagen 18
Icagen Inc, Key Competitors 19
Icagen Inc, Key Employees 20

List of Figures
Icagen Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Icagen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Icagen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Icagen Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Icagen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Icagen Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Icagen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Icagen Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Icagen Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Icagen Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Prologis, Inc.:戦略・SWOT・企業財務分析
    Prologis, Inc. - Strategy, SWOT and Corporate Finance Report Summary Prologis, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Fairfax Media Limited:企業の戦略・SWOT・財務分析
    Fairfax Media Limited - Strategy, SWOT and Corporate Finance Report Summary Fairfax Media Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Dart Container Corporation:企業の戦略・SWOT・財務情報
    Dart Container Corporation - Strategy, SWOT and Corporate Finance Report Summary Dart Container Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Impax Laboratories Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Impax Laboratories Inc (Impax) develops, manufactures and markets generic and branded pharmaceuticals. It offers solid dose and alternative dosage form generic drugs in a broad range of therapeutic areas; and proprietary branded pharmaceutical products for the treatment of central nervous sy …
  • Genting Bhd (GENTING):企業の財務・戦略的SWOT分析
    Genting Bhd (GENTING) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • SuperSonic Imagine SA (SSI):企業の財務・戦略的SWOT分析
    Summary SuperSonic Imagine SA (SuperSonic) operates as a medical device company that develops and supplies ultrasound medical imaging systems for measuring and visualizing tissue elasticity. The company offers an ultrasound system, Aixplorer that finds clinical applications in breast, abdomen, liver …
  • The North West Company Inc. (NWC):企業の財務・戦略的SWOT分析
    The North West Company Inc. (NWC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Victorian WorkCover Authority:企業の戦略的SWOT分析
    Victorian WorkCover Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Superior Energy Services Inc (SPN):企業の財務・戦略的SWOT分析
    Superior Energy Services Inc (SPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • AVEVA Group Plc:企業の戦略・SWOT・財務情報
    AVEVA Group Plc - Strategy, SWOT and Corporate Finance Report Summary AVEVA Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Manchester United Plc:企業の戦略・SWOT・財務分析
    Manchester United Plc - Strategy, SWOT and Corporate Finance Report Summary Manchester United Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Investigator Resources Ltd (IVR):企業の財務・戦略的SWOT分析
    Summary Investigator Resources Ltd (Investigator Resources), formerly Southern Uranium Ltd, is a mining company that offers exploration and development of mineral properties. The company acquires, explores and develops precious and base metal assets in Eyre Peninsulas of South Australia. It operates …
  • Exosomics Siena SpA:企業の製品パイプライン分析2018
    Summary Exosomics Siena SpA (Exosomics Siena) is a biotechnology company that offers research and development services. The company provides services such as contract research, collaborative project management, lead development and technological services. It offers technological services such as sam …
  • Fred Hutchinson Cancer Research Center:企業のM&A・事業提携・投資動向
    Fred Hutchinson Cancer Research Center - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Fred Hutchinson Cancer Research Center Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed repo …
  • W&T Offshore Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    W&T Offshore Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary W&T Offshore Inc (W&T Offshore) is an independent oil and natural gas company. It carries out acquisition, exploitation, development and exploration of oil and natural gas assets both onshore and of …
  • Nexif Energy Management Pte Ltd:電力:M&Aディール及び事業提携情報
    Summary Nexif Energy Management Pte Ltd (Nexif Energy) a subsidiary of Nexif Pte Ltd invests in power projects in partnership with Denham Capital. The company carries out the development and management of power and infrastructure projects in South Asia and South East Asia. It develops and manages po …
  • Bush Industries Inc
    Bush Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Bush Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • The National Commercial Bank:企業の戦略・SWOT・財務分析
    The National Commercial Bank - Strategy, SWOT and Corporate Finance Report Summary The National Commercial Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Red Rock Resorts, Inc. (RRR):企業の財務・戦略的SWOT分析
    Red Rock Resorts, Inc. (RRR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Lansdowne Oil & Gas plc (LOGP):企業の財務・戦略的SWOT分析
    Summary Lansdowne Oil & Gas Plc (Lansdowne Oil & Gas) is an independent oil and gas exploration and production company. The company acquires, explores and develops crude oil and natural gas appraisals in the North Celtic Sea Basin offshore in southern Ireland. It develops Barryroe Field in the North …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆